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Summary A clinico-pathological study of 35 bronchial carcinoid tumours was undertaken. Age. T stage, N
stage, lymph node involvement, number of lymph nodes involved and number of cigarettes smoked per day
were the clinical variables affecting survival. The histological variables related to survival were; mitotic count,
necrosis, nuclear pleomorphism, vascular and lymphatic permeation and an undifferentiated growth pattern.
All these features could be detected with routine histological stains, whereas immunocytochemical methods
for demonstrating neuron specific enolase were of no help in assessing the prognosis. However there was a
tendency for a well differentiated neuroendocrine carcinoma to stain strongly in some areas with carcino-
embryonic antigen.
Experience with the carcinoid tumour is limited
since they account for between only 1 and 6% of
all primary lung tumours (Editorial, 1981).
However because of its varied histological patterns
it is probably under-diagnosed. Traditionally the
lesion has been regarded as benign but it has
become apparent that prognosis may be difficult to
determine from the histological pattern (Abbey-
Smith, 1969). It has also been recently realised that
there is a histological spectrum ranging from
bronchopulmonary carcinoid tumours (typical
carcinoids) through to small cell neuroendocrine
carcinomas (Gould et al., 1983). To determine if
histology, histochemistry and immunocytochemistry
were of any use in determining the prognosis, we
retrospectively examined a series of bronchial
carcinold tumours.
Materials and methods
The SNOP code of the histological files of the
Pathology Department at the Regional Cardio-
thoracic Centre, Wythenshawe Hospital, Manchester
were scanned for the diagnosis of carcinoid tumour
or bronchial adenoma. The latter diagnosis was
made in cases prior to 1970. In all cases the histo-
logical sections were reviewed and only carcinoid
tumours were included in the series. Patients'
records were examined for the following: age, sex,
number of cigarettes smoked per day, site of
tumour, size and treatment (lobectomy, pneumo-
nectomy or other), T stage and N stage. The
minimal follow up was 2 years. The number of
cigarette smokers was compared with the expected
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number of the population using the Office of
Population Census and Surveys Monitor, (1983).
Five ,um sections were cut and stained with
haematoxylin and eosin (H&E), Grimelius (an
argyrophil stain) and diastase PAS (to demonstrate
neutral mucins). Sections were stained by the PAP
technique (Sternberger, 1979) using antisera against
NSE (neuron specific enolase) (Dako) at a dilution
of 1/400 and overnight incubation at 4 C and CEA
(carcinoembryonic antigen (Dako) at 1/800 dilution
and incubation for 30min at room temperature.
Positive controls for CEA were a rectal adeno-
carcinoma known to be CEA positive. The CEA
and NSE antisera were omitted in the negative
controls. As a further control the rectal carcinoma
was stained with NSE.
The following features were noted on the H & E
sections, site (central or peripheral), depth of
invasion and growth pattern. The growth pattern
was classified into one of five categories; insular,
trabecular, tubular or acinar, undifferentiated and
mixed as defined by Soga and Tazawa (1971).
Lymphatic invasion, lymph node involvement,
vascular invasion, oncocytic change, mitotic count
per ten high power fields ( x 40 objective and x 10
eyepieces), presence of necrosis; perineural invasion
and DNA staining of blood vessels were all noted.
Vascular invasion was also assessed using an elastic
van Gieson stain. The tumours were graded using
the criteria of Gould et al. (1983). These were
bronchopulmonary carcinoid, well differentiated
neuroendocrine carcinoma (architectural pattern
similar to a carcinoid tumour but the cells are more
pleomorphic and mitoses are easily seen),
neuroendocrine carcinoma of intermediate sized cell
type (consisting of polygonal fusiform cells,
abundant cytoplasm, many mitoses and peripheral
pallisading) and finally carcinoma of small cell type
(the classical small cell carcinoma).
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The results of each study (clinical and histo-
pathological) were assessed independently and
survival curves were calculated by the life table
method and compared using the log rank test.
Cox's regression analysis was used to identify
continuous variables significantly related to survival
(Peto et al., 1977, Cox, 1972).
Results
Fifty cases had the diagnosis of carcinoid tumour
or adenoma. However the diagnosis was revised in
9 cases to haemangiopericytoma (1) small cell
carcinoma (2) squamous cell carcinoma (3)
squamous and small cell carcinoma (1) adenoid
cystic carcinoma (1) and adenocarcinoma (1). Out
of the 41 cases left, only 35 had notes available for
follow-up. There were 17 bronchopulmonary
carcinoid tumours (typical carcinoids) and 18 well-
differentiated neuroendocrine carcinomas.
There were 21 males and 14 females. The age
range was 18-76 years with a mean of 52 years.
Twenty patients had never smoked and 12 of the
remaining patients smoked between 5 and 30
cigarettes a day. No smoking history was available
in three cases. The number of smokers did not
differ from the population smoking in the period
1972-1982 (10.91 chi-square test). The size of the
tumours ranged from 0.5cm to 8.0cm in diameter.
The sites of the tumour were right (site not
specified) 3, right upper lobe 2, right middle lobe 6,
right lower lobe 8, left (site not specified) 6, left
upper lobe 5 and left lower lobe 5. Twenty-seven
tumours were central (i.e. involving a main
bronchus) and 8 were peripheral. Bronchoscopy
was positive in 21 patients and negative in 14.
Twenty-two cases had a lobectomy and 12 a
pneumonectomy. One case had the tumour treated
by endobronchial resection. Twenty cases were T
stage I, 12 T stage II and 3 T stage III. Twenty-
four cases were N stage 0, 5 were N stage I and 6
N stage II. At the time of analysis 27 patients were
alive with no evidence of disease, 1 patient was
alive with residual tumour, 6 patients had died
from their carcinoid tumours and 1 had died from
myocardial infarction. The architecture was mixed
in 22 cases, relatively few cases having a pure
pattern. There were 6 cases with a pure insular
pattern (Figure 1) but 14 mixed cases had an
insular component. Three cases had a pure
trabecular (Figure 2) pattern but 21 mixed cases
had a trabecular component. Four cases had a
undifferentiated pattern (Figure 3) and this was
also seen in 7 mixed cases. There were no cases
with a pure acinar pattern but 11 cases had a
acinar component (Figure 4) to the mixed cases.
Ten central carcinoid tumours were confined to the
bronchial wall and 17 had extended beyond.
Figure 1 Insular pattern in a bronchial carcinoid.
(H&E, x 313).
Figure 2 Trabecular pattern in a bronchial carcinoid.
(H&E, x 313).
Figure 3 Undifferentiated growth pattern with foci of
necrosis and some nuclear pleomorphism. (H&E,
x 313).PULMONARY CARCINOID TUMOURS 965
Figure 4 Acinar component in a mixed pattern
bronchial carcinoid. (H&E, x 313)
Figure 5 CEA showing strong cytoplasmic staining in
a well differentiated neuroendocrine carcinoma.
(Immunoperoxidase CEA, x 313).
Lymphatic invasion was seen in 8 cases and
lymph node involvement in 9. In four cases no
lymph nodes were received in the laboratory. There
was perineural invasion in 3 cases. Necrosis was
seen in 13 cases and nuclear pleomorphism in 18
cases. Vascular invasion was seen in 9 patients.
Oncocytic change was present in 13 cases including
one oncocytic carcinoid. The mitotic count was 5 or
greater in 5 cases but 27 cases had no mitoses.
Grimelius stain was positive in 21 cases and
negative in 14. Mucin, as shown by diastase/PAS
was seen either in glandular lumina or occasionally
inside the cytoplasm of cells and was present in 8
cases. NSE was positive in all but one case which
was a well differentiated neuroendocrine carcinoma
with much necrosis. When the antisera was omitted
the slides did not stain positively. The rectal adeno-
carcinoma was positive for CEA. CEA showed
strong or moderate (Figure 5) though focal posi-
tivity in seven cases of well differentiated neuro-
endocrine carcinoma whereas it was negative or
showed weak staining in the typical carcinoids.
However five cases with typical carcinoid tumours
showed positivity and two cases of well differen-
tiated neuroendocrine carcinoma were negative for
CEA.
The following clinical variables were significantly
related to survival: age (P=0.012) T stage
(P=0.00015) N stage (P=0.014) lymph node
involvement (P=0.0001) number of lymph nodes
involved (P=0.006) number of cigarettes smoked
per day (P=0.018).
The following histological variables were signifi-
cantly related to survival, mitotic count (P=0.011)
necrosis (P=0.0091), nuclear pleomorphism (P=
0.0164) vascular invasion (P=0.0285), undifferen-
tiated growth pattern (P=0.0019) and lymphatic
invasion (P=0.0211).
Discussion
In the present study age, number of cigarettes
smoked per day, T stage and N stage all affected
the prognosis in bronchopulmonary carcinoid
tumours. It is predictable that T stage and N stage
should affect survival. Similarly it is likely that
elderly people will not withstand surgery as well as
young people because of associated diseases such as
coronary atheroma and the increased risk of
pulmonary embolism. We have shown that smoking
affects survival which is not surprising since it is
likely that such patients would have a higher
incidence of cardiopulmonary diseases. There was
no evidence however that smoking predisposed to
the development of carcinoid tumours since the
number of smokers in the study in the period 1972
to 1982 was not significantly different to the
expected number. The expected number of cigarette
smokers in the population was taken from the
OPCS Monitor (1983). Few studies have addressed
themselves to the possible association of cigarette
smoking and bronchial carcinoid tumours.
Certainly our series was too small to draw any
definite conclusions. In a recent clinical review of
124 bronchial carcinoid tumours (McCaughan et
al., 1985) patients with distal metastases were more
commonly male and smokers. In another series
16/17 patients with atypical pulmonary carcinoids
were smokers (Mills et al., 1982). Thirty-seven of
156 patients in a third paper were smokers
(Paladugu et al., 1985).
There was little difference in the site of the
tumour in our series though a slightly larger
number was seen in the right lung. If several series
are added together (Abbey-Smith, 1969, Turnbull et
al., 1972, Okike et al., 1976, Cooney et al., 1979,
McCaughan et al., 1982) there were 271 tumours in
the right lung and 229 in the left.966 P.S. HASLETON et al.
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Cosini slides. Several ol these feaLturs hlvc becn
mentioned by Arrigoni et atl. (1972) in their
category of 'atypical' pulmonary carcinoids. To
classify such a tumour it had to have one or a
combination of the following histological features;
nuclear pleomorphism, increased mitotic activity,
disorganisation of architecture and foci of tumour
necrosis. They noted atypical features in 23/201
bronchial carcinoids. Seventy per cent of these
patients developed metastases and 30% were dead
at follow-up having survived an average of 27
months.
In our study undifferentiated growth pattern was
the worst prognostic feature but the mitotic count,
nuclear pleomorphism and necrosis were also
statistically significant as was vascular and
lymphatic invasion. Lymph node metastases do not
always imply a poor prognosis (Salyer et al., 1975).
However Hadju et al., (1974) reported decreased
survival in metastatic deeply invasive bronchial
carcinoids. Forty-one of their 204 cases were
pulmonary. Deeply invasive was defined as a
tumour involving 'halfway through the wall of the
organ' or being larger than 2.5cm in diameter.
Regional lymph node metastasis adversely affected
survival in a recent series (McCaughan, 1985).
Undifterentiated growth pattern had a highily
significant affect on survival. Growth pattcerns in
pulmonary and other carcinoids have been shown
to be possibly related to the site of the tumour by
Soga and Tazawa (1971). These authors collected
62 carcinoids from fore, mid and hind gut and
divided them into five types. Type A had solid
nests of tumour cells (insular). Type B, a trabecular
pattern, Type C, a tubular, acinar or rosette like
pattern and Type D showed atypical differentiation.
Mixed was any combination of Types A-D.
Foregut carcinoids, the group bronchial carcinoids
belong to, were found to be predominantly B type.
Seventy per cent of the B type and 67% of mixed
carcinoids were non-reactive i.e. did not stain with
argentaffin stains. Cooney et al. (1979) studied 22
bronchial carcinoids and showed, as in the present
series, that the majority had a mixed pattern.
However in neither study was the type related to
survival. Johnson et al. (1983) addressed themselves
to this question. In their study carcinoids from all
sites were pooled, a point open to question since
the vast majority of their cases originated in the
small bowel. Such cases may present late since
obstruction may occur after development of the
carcinoid syndrome. Also the three types of
carcinoid - fore, mid and hind gut, tend to have
different biological behaviour patterns. As in our
series an undifferentiated growth pattern carried a
worse prognosis. There was a stratif'ication of
median survival times as follows in Johnson's series
(in decreasing order of survival in years), mixed
insular plus glandular 4.4, insular 2.9, trabecular
2.5, mixed insular plus trabecular 2.3, three mixed
types (insular+trabecular+glandular, trabecular+
glandular and trabecular and atypical differen-
tiation), 1.4, glandular 0.9 and undifferentiated 0.5.
The numbers were too small in our study to sec if
a similar pattern was seen in bronchial carcinoids.
NSE was positive in all but one of the cases. The
case not staining was a neuroendocrine carcinoma
with much necrosis. The positivity of carcinoid
tumours with NSE is in accord with the experience
of Shepherd et al. (1984). However it should be
noted that NSE is an unreliable stain for
neuroendocrine cells and recently has been shown
to be positive in tumours of non-endocrine origin
(Vinores et al., 1984). It is our experience that some
adenocarcinomas and squamous cell tumours have
stained positively with this antiserum. It will not
differentiate bronchopulmonary carcinoid tumours
from well-differentiated neuroendocrine carcinoma
or small cell carcinomas. Unfortunately CEA will
not do this either. CEA is positive in small ccil
tumours (Sehested et al., 1981) and thus it is not
surprising that it is seen in bronchial carcinoids
which are part of the same biological spectrum. The
antibody was located inside the cytoplasm as well
as in glandular lumina. However in the well
differentiated neuroendocrine carcinomas there was
a tendency for strong cytoplasmic staining with
CEA. While in some cases it was focal it may give
a guide to biological behaviour of these tumours.
Mucin staining tended to follow the same pattern
as CEA but was less well defined in some cases.
Grimelius stain was positive in 21 cases and
negative in 14. A histolopathologist must be
prepared to diagnose a bronchial carcinoid in the
face of a negative Grimelius. Argentaffin stains are
rarely positive in bronchial carcinoids. Some
authors (Blondal et al., 1980) found all their
carcinoid tumours were argyrophil positive. Three
tumours that did not stain were reclassified into
mucoepidermoid carcinoma, cylindroma and an
'epidermoid' tumour. In a series of 17 atypical
carcinoid tumours the number of argyrophil
positive tumours was increased using a modified
Pascual method (Mills et al., 1982). As in other
series the number of argyrophil positive cells varied
from field to field, an important point when
examining small biopsies. The converse point is also
true that everything argyrophilic is not a carcinoid.
Thus intracellular lactalbumin, lipofuschin, mucin
and glycogen can all show a degree of argyrophilia
(DeLellis et al., 1984).
Finally the classification used may be questioned.
If one accepts that NSE is not an ideal endocrinePULMONARY CARCINOID TUMOURS 967
marker then it has not strictly been shown that
neuroendocrine activity is present in many of our
cases. Looking at Gould's definitions (1983) and
figures it would appear that atypical carcinoids and
probably the malignant carcinoid are equivalent to
the well-differentiated neuroendocrine carcinoma.
However in a series of 63 cases of bronchial
carcinoid tumours currently being studied the
malignant carcinoid usually shows many small cell
areas and larger foci of necrosis than the atypical
carcinoid where a very definite organoid pattern is
seen. The advantage of the new classification is that
the histological spectrum of carcinoid tumours is
shown and perhaps conveys to the clinician, that
like the transitional cell 'papilloma' of bladder, it is
a tumour worthy of follow-up.
References
ABBEY-SMITH, R. (1969). Bronchial carcinoid tumours.
Thor.ax, 24, 43.
ARRIGONI, M.G., WOOLNER, L.B. & BERNATZ, P.E.
(1972). Atypical carcinoid tumors of the lung. J.
Thoracic Cardiovase. Surgerl, 64, 413.
BLONDAL, T., GRIMELIUS, L., NOLL, E., WILANDER, E.
& ABERG, T. (1980). Argyrophil carcinoid tumors of
the lung: Incidence, clinical study and follow-up of 46
patients. Che.st, 78, 840.
COONEY, T., SWEENEY, E.C. & LUKE, D. (1979).
Pulmonary carcinoid tumours: A comparitive regional
study. J. Clin. Pathol., 52, 1100.
COX, D.R. (1972). Regression models and life tables. J.
Roy. Statist. Soc., B. 34, 187.
DELELLIS, R.A., DAYCIL, Y. & WOLFE, H.J. (1984).
Carcinoid tumors: Changing concepts and new
perspectives. Anm. J. Surg. Pathol., 8, 295.
EDITORIAL, (1981). Bronchial adenomas. B. Med. J., 282,
252.
GOULD, V.E., LINNOLD, R.F., MEMOLI, V.A. & WARREN,
W.H. (1983). Neuroendocrine cells and neuroendocrine
neoplasms of the lung. Pathol. Ann., 18, 287.
HADJU, S.I., WINAWER, S.J. & LAIRD MYERS, W.P.
(1974). Carcinoid tumors: A study of 204 cases. Anm. J.
Clin. Pathol., 61, 521.
JOHNSON. L.A., LAVIN, P., MOERTEL. C.G. & II others
(1983). Carcinoids: The association of histologic
growth pattern and survival. Cancer, 51, 882.
McCAUGjHAN, B.C., MARTINI, H. & BAINS, M.S. (1985).
Bronchial carcinoids: Review of 124 cases. J. Thoracic
Cardfioicasc. Surg., 89, 8.
MILLS, S.E., WALKER, A.N., COOPER, P.H. & KRON, I.L.
(1982). Atypical carcinoid tumour of the lung: A
clinicopathologic study of 17 cases. Anm. J. Surg.
Pithol., 6, 643.
OFFICE OF POPULATION CENSUSES AND SURVEYS
MONITOR (1983).
OKIKE, N., BERNATZ, P.E. & WOOLNER, L.W. (1976).
Carcinoid tumors of the lung. Ann. Thoracic Surg., 22,
270.
PALADUGU, R.R., BENFIELD, J.R., PAK, H.Y., ROSS, R.K.
& TEPLITZ, R.L. (1985). Bronchopulmonary
Kulchitzsky cell carcinomas: A new classificationl
scheme for typical and atypical carcinoids. Cancer, 55,
1303.
PETO, R., PIKE, M.C., ARMITAGE, P. & 7 others (1977).
Design and analysis of randomised clinical trials
requiring prolonged observation of each patient. II
analysis and examples. Br. J. Cancer, 35, 1.
SALYER. D.C., SALYER, W.R. & EGGLESTON, J.C. (1975).
Bronchial carcinoid tumors. Cancer, 36, 1522.
SEHESTED, M., HIRSCH, F.R. & HON-JENSEN, K. (1981).
Immunoperoxidase staining for carcinoembryonic
antigen in small cell carcinoma of the lung. Eur. J.
Clin. Oncolgj. 17, 1125.
SHEPHERD, M.N., CORRIN, B., BENNETT. M.H..
MARANGOS, P.J., BROWN, S.R., POLAK, J.M. (1984).
Immunocytochemical localisation of neuron specific
enolase (NSE) in small cell carcinoma and carcinoid
tumours of the lung. Histopathologv, 8, 171.
SOGA, J. & TAZAWA, K. (1971). Pathologic analysis of
carcinoids: Histologic re-valuation of 62 cases. Cancer,
28, 990.
STERNBERGER, L.A. (1979). The unlabeled antibody
peroxidase - antiperoxidase (PAP) method. In
Inimunoc1)itochenlistrl 2nd Edn. p. 104. John Wiley:
New York.
TURNBULL, A.D., HUVOS, A.G., GOODNER, J.T. &
BEATTIE, E.J. (1972). The malignant potential of
bronchial adenoma. Ann. Thoracic Surg., 14, 453.
VINORES, S.A.. BONNIN, J.M.. RUBINSTEIN, L.J. &
MARANGOS, P.J. (1984). Immunohistochemicl
demonstration of neuron specific enolase in neoplasmis
of the CNS and other tissues. Arch. Pa/thol. Liab. Mcd.,
108, 536.